FDA Advisory Panel Narrowly Votes Against New ALS Drug

THURSDAY, March 31, 2022 -- In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for amyotrophic lateral sclerosis (ALS). The panel ' s decision had been closely...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news